COHR

Business Context and Reporting Period

Company: II-VI Incorporated (Note: Filing header lists "COHERENT CORP." but content confirms II-VI Incorporated).

Reporting Period: Quarterly Report (Form 10-Q) for the three months ended September 30, 2005.

Business Overview: The company develops, manufactures, and markets high-technology materials and derivative products for industrial, medical, military, security, and aerospace applications. Operations are organized into four segments: Infrared Optics, Near-Infrared Optics, Military Infrared Optics, and the Compound Semiconductor Group (which includes the acquired Marlow Industries, Inc.).

Key Financial Metrics

Liquidity: The company maintains a $60.0 million secured credit facility with $19.0 million available as of September 30, 2005. Total debt obligations include a $30.0 million term loan and a $10.5 million line of credit balance.

Material Changes vs. Prior Period

• Revenue Growth: Revenues increased 34% year-over-year. Excluding the $8.0 million contribution from the Marlow acquisition (completed Dec 2004), organic revenue growth was 15%.
• Profitability: Net earnings rose 20% to $6.7 million. This was driven by revenue growth and operating efficiencies, partially offset by a higher effective tax rate (29.5% vs. 27.0%) and increased stock-based compensation expenses due to the adoption of SFAS 123R.
• Segment Performance:
  • Infrared Optics: Revenues up 25%; Segment earnings up 23%.
  • Near-Infrared Optics: Revenues up 12%; Segment earnings up 79%.
  • Military Infrared Optics: Revenues down 4% due to production challenges on the "Arrowhead Program"; Segment loss of $0.5 million vs. earnings of $0.3 million prior year.
  • Compound Semiconductor Group: Revenues up 223% (driven by Marlow inclusion); Segment loss narrowed to $0.4 million from $0.5 million.
• Bookings: Increased 58% to $59.3 million. Excluding Marlow, organic bookings grew 23%.

Guidance, Outlook, and Risks

• Accounting Changes: The company adopted SFAS 123R (Share-Based Payment) effective July 1, 2005, resulting in a $0.7 million stock compensation expense for the quarter and a restatement of prior period financials.
• Acquisitions: Completed the purchase of the remaining 25% interest in II-VI Deutschland GmbH for approximately $1.6 million in July 2005.
• Unusual Items: Recorded $0.8 million in "Other income" from the receipt of a jury verdict award in a trade secret lawsuit. Also received $0.2 million from a business interruption insurance claim.
• Risks & Contingencies:
  • Production Yields: Low yields on military targeting systems (Arrowhead Program) negatively impacted the Military Infrared Optics segment.
  • Raw Materials: Selenium raw material costs doubled, negatively impacting gross margins in the Infrared Optics segment.
  • Foreign Exchange: Exposure to Japanese Yen, Euro, and Pound Sterling fluctuations. The company uses forward contracts to hedge transactional exposure.
  • Interest Rates: Floating rate debt exposes the company to interest rate risk, partially mitigated by interest rate caps.

Investor Verification Checklist

• Organic Growth: Verify the sustainability of the 15% organic revenue growth excluding the Marlow acquisition impact.
• Military Segment Turnaround: Monitor resolution of production yield issues in the Military Infrared Optics segment (Arrowhead Program) to assess return to profitability.
• Margin Pressure: Assess the long-term impact of rising selenium costs and the lower-margin profile of the Marlow acquisition on overall gross margins.
• Debt Service: Review the company's ability to service the $43.5 million debt load, particularly with quarterly principal payments on the term loan commencing January 2006.
• Stock Compensation: Confirm the ongoing impact of SFAS 123R adoption on future earnings per share.